Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CYDF - Cyber Defense Systems, Inc. Common Stock
Declaration Date:
-- Ex Date:
-- Record Date:
9/17/2007 Payment Date:
--
Dividend Type:
Spin Off Dividend Amount:
+
Notes:
One share of Techsphere Systems International, Inc. for every four shares held. P/D & X/D: Pending SEC Effectiveness.
VisiCalc!
You've got a lot of people pulling for you and your Mom.
The best to you both.
Would that be like 3 people wishing they were screwed?
And just what exactly is wrong with that?
( I saw Serf talkin to you the other day, wtg)
Way to raise the hit count on a blog, maybe?
Smokin!
Could I get a chart on WEL?
tia
JL
GOVX-GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
Last update: 9/12/2007 1:17:00 PMATLANTA, Sept 12, 2007 /
PRNewswire-FirstCall via COMTEX/ -- GeoVax Labs, Inc. (GOVX), an Atlanta based biotechnology company, announced the presentation of successful human trial results for its HIV/AIDS vaccines at the AIDS Vaccine 2007 Conference held August 20-23, 2007 in Seattle, Washington. GeoVax HIV/AIDS human trial results were presented by Dr. Paul Goepfert, MD in a talk "HIV-1 DNA Prime followed by Recombinant MVA Boost is Well Tolerated and Immunogenic When Administered to Healthy Seronegative Adults." Dr. Goepfert, from the University of Alabama-Birmingham, is Protocol Chair of HVTN 065, a series of human clinical trials currently evaluating GeoVax's HIV/AIDS vaccine. GeoVax HIV/AIDS vaccine trial data was presented to over 900 AIDS researchers at the week long conference. Conference Chair, Dr. Lawrence Corey stated, "It has become clear that a preventative vaccine is essential to controlling the global AIDS epidemic." The AIDS Vaccine 2007 Conference was organized under the guidance of the Global HIV Vaccine Enterprise, an alliance of independent global organizations dedicated to accelerating preventative AIDS vaccine development. The conference reported the AIDS epidemic continuing as a global threat with the disease increasing in every region of the world, especially East and Central Asia and Eastern Europe where AIDS incidence was 21% higher in 2006 than in 2004. Key GeoVax HIV/AIDS Vaccine Human Trial conclusions presented at the AIDS Vaccine 2007 Conference included:
-- GeoVax DNA and MVA vaccines are safe and immunogenic (stimulate anti- HIV/AIDS immune responses) at both low (1/10th) dose and full doses. -- GeoVax vaccines were well tolerated with no or mild local and systemic reactions in the majority of trial participants. -- 80% of both the low and full dose trial participants responded to the vaccine which stimulated highly desirable anti-HIV T-cell (white blood cell) and antibody responses. -- More volunteers had antibody responses to the full dose than to the 1/10th dose vaccine, whereas response rates for T cells were similar for the 1/10th and full dose. -- 2nd MVA vaccination positively increased the number of CD8 T cell responders and antibody responders. -- Excellent results led to authorization to start two new trials with GeoVax HIV/AIDS vaccines which began in June 2007.These human trials, utilizing GeoVax's HIV/AIDS vaccines, are conducted by the HIV Vaccine Trials Network (HVTN) based in Seattle, Washington. The HVTN, funded and supported by the National Institutes of Health (NIH), is the largest worldwide clinical trials program devoted to the development and testing of HIV/AIDS vaccines. Preclinical work enabling development of the clinical evaluation of GeoVax's DNA and MVA vaccines was also funded and supported by the NIH National Institute of Allergy and Infectious Diseases (NIAID). About GeoVax Labs, Inc. () GeoVax Inc. is an Atlanta, Georgia USA biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's vaccine technology is protected by 20 issued and filed patent applications.
GeoVax's DNA and Recombinant MVA HIV/AIDS vaccines: -- Uses DNA for priming the vaccine responses and recombinant MVA to boost the vaccine response (DNA/MVA vaccine) -- Protected 22 of 23 (96%) non-human primates for over 3-1/2 years post- infection with an AIDS causing virus - 5 of 6 non-vaccinated controls died of AIDS within the 1st year of infection. These trials used a prototype SIV/HIV vaccine for the HIV vaccine that is being advanced in human trials -- Are manufactured and tested under GMP/GLP - EMEA (EU) and FDA guidelines -- Satisfactorily completed early Phase 1 human clinical trials for a DNA HIV/AIDS vaccine -- Are currently in 4 ongoing human trials started in 2006 with positive immune responses reported in the majority of vaccine recipients as well as good vaccine safety -- Are in planning stage for a larger Phase 2 trial tentatively scheduled for 2008For further information, contact Donald Hildebrand or Jennifer Nelms at (404) 727-0971 or visit . Safe Harbor Statement: All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether; GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be determined to be safe for use in humans, GeoVax's vaccines will be effective in preventing AIDS in humans, the vaccines will receive the regulatory approvals necessary to be licensed and marketed, GeoVax can raise the required capital to complete development of its vaccines, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward looking statements involving certain risks and uncertainties including, without limitations, risks detailed in the Companies Securities and Exchange Commission filings and report. SOURCE GeoVax Labs, Inc.
Copyright (C) 2007 PR Newswire. All rights reserved
At least he didn't write this P/R.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Hybrid Dynamics Corporation
(Exact name of registrant as specified in its charter)
Nevada
31-1041835
(State or other jurisdiction of incorporation
or organization)
(I.R.S. Employer
Identification No.)
892 North 340 East, American Fork UT 84003
(Address of Principal Executive Offices and Zip Code)
Hybrid Dynamics Corporation 2007 Consultant Stock Plan
(Full title of the plan)
Paul Ressler, President
Hybrid Dynamics Corporation
892 North 340 East, American Fork UT 84003
(801) 756-5831
(Name and address and telephone number of agent for service)
With copies to:
Charles A. Koenig
Attorney-At-Law
326 South High St, Suite 300
Columbus, Ohio 43221
(614) 241-5902
(Name and address and telephone number)
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
Amount to be
Registered
Proposed Maximum
Offering Price Per
Share (2)
Proposed Maximum
Aggregate Offering
Price (2)
Amount of
Registration Fee
Common Stock
$0.00015 par value
385,000Shares (1)
$0.03 Per Share
$11,550
$0.36
Hello Bags;
I knew that was comin as soon as I posted.
Was referring to the wallet. About 5 mil.
chasing the ask first thing in the am might get it above .001!
I was thinkin the same ting!
Was wondering how long it would take for you to catch that!
I gotta board mark this, It's getting too funny to miss.
Gotta love this guy:
JMCP Corp.: JMCP Corp.: JMCP Corp.: (Pink Sheet: JMCP) James Monroe Capital Corp. conducts due diligents the Shipping Industry.
Senior moment.
Yes.
The stock carries the divi until ex-date.
Congrats and good luck.
SA my one month pick is MCII. $1.85 one month price.
Good luck to everyone.
T-2
You got cows? Hell, put 'em on it!
All that water makes a big difference
at the end of season.
My Pecan (first year produce), grafted,
is doing great.
Best luck to you;
JL
Posts are not resetting after having been read.
This is intermittent but quite often with T/A and
Alerts boards.
Cache is cleared often, no effect.
Any Ideas?
Hope it's not due to iggy's as I use them for good
reason.
Hybrid Dynamics Corporation Announces Acquisitions and Several Corporate Actions
Last update: 8/28/2007 2:23:01 PM
AMERICAN FORK, Utah, Aug 28, 2007 (BUSINESS WIRE) -- On August 10, 2007, Hybrid Dynamics Corporation, a Nevada corporation (the "Company"), effected a one-for-100 reverse split of its common stock, par value $0.00015 per share. In order to effect the reverse split, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada. Prior to the filing, the form of Certificate of Amendment was approved by a majority of the Company's stockholders and by the Company's board of directors. The reverse stock split reduced the number of our issued and outstanding shares from 24,215,695 to approximately 257,933. No stockholder received less than 100 shares of our common stock as a result of the reverse stock. As a result of the reverse split, the Company's trading symbol on the OTC Bulletin Board was changed to "HBDY.OB" on August 14, 2007. On August 28, 2007 Hybrid issued 2,000,000 shares of common stock in acquisition of Fire Ant Corporation ("FAC") and 1,410,000 shares of common stock in acquisition of Infomac Corporation. Infomac is a distributor with Microtrak GPS, Inc., a manufacturer of GPS enabled tracking devices for cars, motorcycles and mobile equipment. FAC is the holder of proprietary technology to a spring-loaded, regenerative braking system for light electric and hybrid vehicles. In addition the Company agreed to issue 1,527,000 shares in payment of consulting services. Upon the completion of the reverse split, the acquisitions of Infomac and FAC and consulting fee payments, Hybrid has 5,226,624 shares of common stock outstanding on a fully diluted basis. Hybrid manufactures and distributes recreational electric vehicles and develops motor-control systems and hybrid drive-train technologies for use in electric and hybrid motorized vehicles. FORWARD-LOOKING STATEMENTS This release contains certain "forward-looking statements" relating to the business of Hybrid and its subsidiary companies, which can be identified by the use of forward-looking terminology such as "believes, expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, and concentration in a single customer, raw material costs, market acceptance, future capital requirements, and competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission. Hybrid is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. SOURCE: Hybrid Dynamics Corporation
Hybrid Dynamics CorporationPaul Ressler, 801-756-5831
Copyright Business Wire 2007
Could I interest you both in some luscious KSWJ.
I've had it a couple of years and it is quite
ripe!
Do you feel so insignificant that you have to post kudos
for others to see?
Scams are many here. If it's pink, just pick one.
Good luck.
FYI:
TDA did this:
CASH IN LIEU OF FRACTIONAL SHARES (SLTS)
A stock I shouldn't have bought but I called and said
that I did not authorize that sale and I wanted my one
share round-up. Apologies were made and I was offered
the price of the current "Last" plus 5 free trades.
Not a bad return on a bad buy.
I kinda kneejerk the round-ups. All have worked well
except PAVC.
Link!
Loss of interest?
The best response I can think of is "GIGO", garbage in,
garbage out. Unless it includes r/m or change of ownership etc.
My experience has been that they all drop at some point, if
not at, then near the beginning.
No round-up, no value. The split isn't high enough.
You can play the dump after the r/s maybe...
Great! That will free-up some Iggy's.
Tequila will fix that problem every time!
Works for me :)
Set um up, knock em down. Liken this board today.
I've been drinking beer and you want me to do math?
Mañana on that.
There are many conservative "investors" that read
these boards and this, apparently would be a good
stock for them. Not many long situations at this
end of the barrel.
Get the gals on this. As they say, "it moves on
air"
Those were some damn good numbers!
Glad you have them too.
Are you the one standing?